Falsification of biotechnology drugs: current dangers and/or future disasters?
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Falsification of biotechnology drugs: current dangers and/or future disasters?
- Published In:
- Journal of pharmaceutical and biomedical analysis, 161, 175-191 (2018)
- Authors:
- Janvier, Steven, De Spiegeleer, Bart(3), Vanhee, Celine, Deconinck, Eric
- Database ID:
- RPEP-03725
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03725APA
Janvier, Steven; De Spiegeleer, Bart; Vanhee, Celine; Deconinck, Eric. (2018). Falsification of biotechnology drugs: current dangers and/or future disasters?. Journal of pharmaceutical and biomedical analysis, 161, 175-191. https://doi.org/10.1016/j.jpba.2018.08.037
MLA
Janvier, Steven, et al. "Falsification of biotechnology drugs: current dangers and/or future disasters?." Journal of pharmaceutical and biomedical analysis, 2018. https://doi.org/10.1016/j.jpba.2018.08.037
RethinkPeptides
RethinkPeptides Research Database. "Falsification of biotechnology drugs: current dangers and/or..." RPEP-03725. Retrieved from https://rethinkpeptides.com/research/janvier-2018-falsification-of-biotechnology-drugs
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.